<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(7)</volume><submitter>Yao Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Using continuous glucose monitoring (CGM) in critically ill adult patients requiring insulin therapy has increased with inconsistent results. Thus, we conducted a meta-analysis to assess the effect of CGM and frequent point-of-care (POC) measurements in such a patient population.&lt;h4>Methods&lt;/h4>We searched PubMed, Embase, Cochrane Library, China national knowledge infrastructure, and Wanfang for relevant articles from inception to Jan 15, 2022. Randomized controlled trials (RCTs) were considered if they focused on critically ill patients who required insulin and were treated with CGM or any POC measurements. We used the Cochrane risk evaluating tool to assess study quality. Subgroup analysis and publication bias were also conducted.&lt;h4>Results&lt;/h4>We finally included 19 </pubmed_abstract><journal>American journal of translational research</journal><pagination>4757-4767</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9360883</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Subcutaneous continuous glucose monitoring in critically ill patients during insulin therapy: a meta-analysis.</pubmed_title><pmcid>PMC9360883</pmcid><pubmed_authors>Zhao YH</pubmed_authors><pubmed_authors>Yao Y</pubmed_authors><pubmed_authors>Zheng WH</pubmed_authors><pubmed_authors>Huang HB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Subcutaneous continuous glucose monitoring in critically ill patients during insulin therapy: a meta-analysis.</name><description>&lt;h4>Background&lt;/h4>Using continuous glucose monitoring (CGM) in critically ill adult patients requiring insulin therapy has increased with inconsistent results. Thus, we conducted a meta-analysis to assess the effect of CGM and frequent point-of-care (POC) measurements in such a patient population.&lt;h4>Methods&lt;/h4>We searched PubMed, Embase, Cochrane Library, China national knowledge infrastructure, and Wanfang for relevant articles from inception to Jan 15, 2022. Randomized controlled trials (RCTs) were considered if they focused on critically ill patients who required insulin and were treated with CGM or any POC measurements. We used the Cochrane risk evaluating tool to assess study quality. Subgroup analysis and publication bias were also conducted.&lt;h4>Results&lt;/h4>We finally included 19 </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T10:45:17.049Z</modification><creation>2025-04-04T10:45:17.049Z</creation></dates><accession>S-EPMC9360883</accession><cross_references><pubmed>35958452</pubmed></cross_references></HashMap>